Steve E. Krognes
2018
In 2018, Steve E. Krognes earned a total compensation of $4M as Chief Financial Officer and Treasurer at Denali Therapeutics, a 243% increase compared to previous year.
Compensation breakdown
| Bonus | $393,682 |
|---|---|
| Option Awards | $2,948,616 |
| Salary | $455,260 |
| Stock Awards | $179,673 |
| Other | $24,000 |
| Total | $4,001,231 |
Krognes received $2.9M in option awards, accounting for 74% of the total pay in 2018.
Krognes also received $393.7K in bonus, $455.3K in salary, $179.7K in stock awards and $24K in other compensation.
Rankings
In 2018, Steve E. Krognes' compensation ranked 2,788th out of 14,244 executives tracked by ExecPay. In other words, Krognes earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,788 out of 14,244 | 80th |
Division Manufacturing | 1,034 out of 5,759 | 82nd |
Major group Chemicals And Allied Products | 354 out of 2,122 | 83rd |
Industry group Drugs | 291 out of 1,811 | 84th |
Industry Biological Products, Except Diagnostic Substances | 63 out of 339 | 81st |
Source: SEC filing on April 18, 2019.
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2018.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019